Qube Research & Technologies Ltd - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 362 filers reported holding NOVOCURE LTD in Q2 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2023$4,563,724
-11.1%
75,885
+11.0%
0.02%
-50.0%
Q4 2021$5,134,000
-79.7%
68,385
-40.0%
0.04%
-86.1%
Q2 2021$25,289,000
+915.2%
114,007
+504.9%
0.29%
+620.0%
Q1 2021$2,491,000
-63.3%
18,846
-83.5%
0.04%
-60.0%
Q2 2020$6,784,000
+1404.2%
114,408
+1608.6%
0.10%
+426.3%
Q1 2020$451,0006,6960.02%
Other shareholders
NOVOCURE LTD shareholders Q2 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders